Versant Capital Management’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$97.8K Buy
3,800
+290
+8% +$6.72K 0.01% 951
2026
Q1
$72.2K Buy
3,510
+2,207
+169% +$49.7K 0.01% 1029
2025
Q4
$30.9K Buy
1,303
+564
+76% +$13.7K ﹤0.01% 1367
2025
Q3
$18.4K Hold
739
﹤0.01% 1634
2025
Q2
$17K Hold
739
﹤0.01% 1617
2025
Q1
$16.6K Hold
739
﹤0.01% 1443
2024
Q4
$14.4K Buy
+739
New +$14.6K ﹤0.01% 1204

Other funds holding PRVA

Versant Capital Management's PRVA Position: Q2 2026 in Review

Versant Capital Management increased its Privia Health (PRVA) stake by 8.3% in Q2 2026, buying an estimated $6.72K and bringing the position to 3,800 shares worth $97.8K. The position accounts for 0.01% of the portfolio, ranked #951.

Versant Capital Management first reported a position in PRVA in Q4 2024 and has held it in 7 quarters since. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Versant Capital Management held 3,800 shares of Privia Health worth $97.8K as of Q2 2026.
  • Versant Capital Management bought 290 Privia Health shares in Q2 2026, an estimated $6.72K.
  • Privia Health made up 0.01% of Versant Capital Management's portfolio in Q2 2026, its #951 holding.
  • Versant Capital Management first reported a position in Privia Health in Q4 2024 and has held it in 7 quarters since.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.